missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human EGF Recombinant Protein
EGF is a bioactive protein intended for use in cell culture applications
Brand: Gibco™ PHG0311
This item is not returnable.
View return policy
Description
Human EGF Recombinant Protein for Western Blot, IHC, ELISA, Ctrl, FN
EGF has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin.- This product is provided as lyophilized and carrier-free
- High purity: no interference from other proteins or contaminants
- High biological activity: more results with less protein
- Proven compatibility: to help ensure growth factors are of the highest quality, each protein is analyzed for purity along with structural homogeneity to ensure a biologically active protein
- High biological activity: in-house activity testing of recombinant proteins includes cell proliferation, cytotoxicity, chemotaxis, calcium flux, secondary cytokine up-regulation, induction of surface antigen expression, anti-viral, and protease assays; specific activity is determined by the dose dependent proliferation of mouse BALB/3T3 cells
Shipping Condition: Wet Ice.
Specifications
Cell Culture | |
6.2 kDa | |
100 μg | |
Human | |
Carrier-Free | |
100 μg | |
E. coli | |
Recombinant, Ligand | |
EGF (Epidermal Growth Factor) | |
Gibco™ |
1950 | |
Sequential Chromatography | |
EGF | |
This product is provided as lyophilized and carrier-free. Store lyophilized recombinant human EGF at 2–8°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at <-20°C. Avoid repeated freeze⁄thaw cycles. | |
< 0.1 ng/μg | |
Wet Ice | |
Growth Factors & Receptors | |
Lyophilized | |
Stem Cell Research, Oncology | |
95 % |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction